Last reviewed · How we verify
NCT03121040
Clinical Trial for Vespa Amino Acid Mixture (VAAM®)
NA trial testing Vespa amino acid mixture in Sports Injury in 10 participants. Completed in 22 July 2009.
16 July 2009
Quick facts
| Lead sponsor | Shanghai Meiji Health Science and Technology Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 10 |
| Start date | 2 May 2009 |
| Primary completion | 16 July 2009 |
| Estimated completion | 22 July 2009 |
Drugs / interventions tested
- Vespa amino acid mixture
Conditions studied
- Sports Injury — all drugs for Sports Injury →
Sponsor
Shanghai Meiji Health Science and Technology Co., Ltd.
Who can join
Adults 16 to 18, any sex, with Sports Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
ATP is generated mainly through anaerobic metabolism during strenuous exercise, which is then followed by the generation of lactic acid. However, this process can only be maintained for a short time, approximately one minute, because the accumulation of lactic acid in the muscles may affect muscle performance. The efficiency of lactic acid metabolism is one of the most important reasons for endurance improvement. The purpose of this study was to evaluate the impacts of the daily ingestion of a commercially available Vespa amino acid mixture (VAAM®) beverage on blood parameters that are related to fatigue, muscle damage and immunity in healthy, young athletes during middle-distance running exercises. VAAM® contains 17 types of amino acids at a certain ratio, and evaluations were completed during 10 weeks of consecutive required speed and strength running tests.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03121040
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sports Injury
Currently open trials in the same condition.
- NCT06739785 — Turkish Translation of SportsConcussion Assesment Tool 6 · active not recruiting
Other Shanghai Meiji Health Science and Technology Co., Ltd. trials
Trials by the same sponsor.
- NCT04848571 — Effects of Chinese Medicine on Early Pregnant Women · completed
- NCT04651023 — Shanghai Meiji Health Science and Technology Co., Ltd · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03121040 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Meiji Health Science and Technology Co., Ltd.
- Last refreshed: 19 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03121040.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing